Emma Health Technologies is a biotechnology and healthcare startup, founded in 2002 and headquartered in the United States. The company's flagship product, MyEMMA, is an Electronic Medication Management Assistant designed to provide clinical services through a wellness portal. MyEMMA offers pharmacist-driven medication adherence, enabling patients to receive the necessary clinical support while staying at the lowest appropriate level of care. The company aims to create collaborative care across the continuum by leveraging interventional analytics and real-time information for data-driven wellness decisions. In August 2016, Emma Health Technologies secured a $455.00K debt financing investment, signaling investor confidence in the company's innovative approach to medication management and healthcare technology. The startup operates in the medical devices and senior care industries, positioning itself at the intersection of healthcare and technology. As the company continues to expand its product offerings, such as the EMMA eKit for first dose medication needs, it seeks to increase revenues, enhance retention, and proactively manage medication adherence for better patient outcomes. With its focus on leveraging technology for improving healthcare delivery, Emma Health Technologies presents an intriguing proposition for potential investors in the healthcare and biotechnology sectors.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Debt Financing | $455.00K | - | 18 Aug 2016 | |
Venture Round | $976.00K | - | 01 Apr 2016 | |
Venture Round | $7.12M | - | 15 Jan 2015 | |
Venture Round | $11.45M | - | 07 Jan 2011 | |
Venture Round | $9.42M | - | 31 May 2010 |
No recent news or press coverage available for Emma Health Technologies .